Clinical Trial: A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules in Combination with Bevacizumab and Temozolomide in Patients with Recurrent/Progressive High-Grade Glioma (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules in Combination with Bevacizumab and Temozolomide in Patients with Recurrent/Progressive High-Grade Glioma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132610

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Chinese People's Liberation Army

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342460

Published by HT Digital Content Services with permission from Health Dail...